原文网址:http://www.edqm.eu/en/certification-164.html
Certification of Substances Division
MME/CB
PUBLIC DOCUMENT
((LEVEL 1))
PA/PH/CEP (14) 45
Strasbourg, August 2014
Certification of suitability to Monographs of the European Pharmacopoeia
MONTHLY REPORT PUBLICATION
July 2014
2014年7月月报
Address: 7 Allée Kastner, CS 30026
F-67081 Strasbourg (France)
Tel: +33 (0) 3 88 41 30 30 – Fax: +33 (0) 3 88 41 27 71 - e-mail: cep@edqm.eu
Internet: http://www.edqm.eu
New applications for CEP 新CEP申报
| | |
Nr of applications received 收到申请数量 | | |
| | |
Others (TSE, herbal)其它(TSE,草药) | | |
| | |
Nr of CEPs granted (all) CEP颁发数量(所有) | | |
| | |
Actual time vs. deadlines (days) 实际时间VS最后期限(天) (+) means delay; (-) means in advance (+)表示延迟;(-)表示提前 | | |
Rate of dossiers treated in time (%) 申报资料及时处理率(%) | | |
Revisions (including notifications and renewals) of CEP applications
CEP申报修订(包括通知和更新)
| | |
Nr of applications received 收到申请数量 | | |
| | |
Others (TSE, herbal)其它(TSE,草药) | | |
| | |
Nr of revised CEPs granted (all) 修订后CEP颁发数量(所有) | | |
| | |
Actual time vs. deadlines (days) 实际时间VS最后期限(天) (+) means delay; (-) means in advance (+)表示延迟;(-)表示提前 | | |
Rate of dossiers treated in time (%) 申报资料及时处理率(%) | | |
Answers to an EDQM deficiency letter 对EDQM缺陷信的回复
| | |
Nr of answers received 收到回复数量 | | |
| | |
Others (TSE, double, herbal) 其它(TSE,双证,草药) | | |
| | |
| | |
Actual time vs. deadlines (days) 实际时间VS最后期限(天) (+) means delay; (-) means in advance (+)表示延迟;(-)表示提前 | | |
Rate of dossiers treated in time (%) 资料及时处理率(%) | | |
Inspections 现场检查
Suspended /withdrawn CEPs 证书搁置和撤销
| | |
Nr of CEPs supended 搁置CEP证书数量 | | |
Nr of CEPs expired 过效期CEP证书数量 | | |
Nr of CEPs withdrawn by EDQM 由EDQM撤销的证书数量 | | |
Nr of CEP withdrawn by holder 由持有人撤销的证书数量 | | |
Information published on the EDQM Website (www.edqm.eu)
在EDQM官网上颁布的相关信息
l CEP Suspension: As a result of an inspection of the manufacturing site(s) 现场检查后搁置CEP
n 31/07/14 Bupivacaine hydrochloride CEP 2001-013
n 31/07/14 Lidocaine hydrochloride CEP 2001-014
n 31/07/14 Ketoprofen CEP 2002-097
n 31/07/14 Ticlopidine hydrochloride CEP 2002-106
n 31/07/14 Metoprolol tartrate CEP 2004-087
n 31/07/14 Lidocaine CEP 2004-156
n 31/07/14 Dipyridamole CEP 2004-204
n 31/07/14 Torasemide, anhydrous CEP 2009-036
n 31/07/14 Articaine hydrochloride CEP 2009-137
n 31/07/14 Mepivacaine hydrochloride CEP 2010-129
l 15/07/2014: List of assessors (updated 07/07/14) 评审员清单更新
注:根据EDQM数据库,因现场检查被搁置的10份CEP均为意大利某公司所有:
根据EMA官网公布的GMP不符合信息,该检查发生在2014年5月13日,是由意大利药监局(AIFA)会同意大利警方及意大利海关执行的飞行检查。该公司被要求召回相关批次,该场所原料药生产被禁售,药监局收回其GMP证书。
GMP违规情况详见http://eudragmdp.ema.europa.eu/inspections/gmpc/searchGMPNonCompliance.do?ctrl=searchGMPNCResultControlList&action=Drilldown¶m=24002